相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects and Mechanism of Action of Artemisinin on Mitochondria of Plasmodium berghei
Hong-ping Hou et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2020)
In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
Moussa Lingani et al.
MALARIA JOURNAL (2020)
A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites
Jakob Birnbaum et al.
SCIENCE (2020)
Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal
Mamadou Alpha Diallo et al.
SCIENTIFIC REPORTS (2020)
Piperaquine resistant CambodianPlasmodium falciparumclinical isolates: in vitro genotypic and phenotypic characterization
Nonlawat Boonyalai et al.
MALARIA JOURNAL (2020)
Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial
Abdoul Habib Beavogui et al.
MALARIA JOURNAL (2020)
Emergence and clonal expansion of in vitro artemisinin-resistantPlasmodium falciparum kelch13R561H mutant parasites in Rwanda
Aline Uwimana et al.
NATURE MEDICINE (2020)
No evidence of amplifiedPlasmodium falciparum plasmepsin IIgene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border
Fang Huang et al.
MALARIA JOURNAL (2020)
Lack of Convincing Evidence of Artemisinin Resistance in India
Charlotte Rasmussen et al.
CLINICAL INFECTIOUS DISEASES (2019)
Antimalarial drug resistance in Africa: the calm before the storm?
Melissa D. Conrad et al.
LANCET INFECTIOUS DISEASES (2019)
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
Rob W. van der Pluijm et al.
LANCET INFECTIOUS DISEASES (2019)
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against
Sanjeev Krishna
MALARIA JOURNAL (2019)
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Nicholas J. White
MALARIA JOURNAL (2019)
Decreased K13 Abundance Reduces Hemoglobin Catabolism and Proteotoxic Stress, Underpinning Artemisinin Resistance
Tuo Yang et al.
CELL REPORTS (2019)
Novel pfkelch13 Gene Polymorphism Associates With Artemisinin Resistance in Eastern India
Sabyasachi Das et al.
CLINICAL INFECTIOUS DISEASES (2019)
Current scenario and future strategies to fight artemisinin resistance
Rahul Pasupureddy et al.
PARASITOLOGY RESEARCH (2019)
Monitoring the Efficacy and Safety of Artemisinin-Based Combination Therapies: A Review and Network Meta-analysis of Antimalarial Therapeutic Efficacy Trials in Cameroon
Solange Whegang Youdom et al.
DRUGS IN R&D (2019)
Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone
Samuel J. Smith et al.
ACTA TROPICA (2018)
Inactivation of Plasmepsins 2 and 3 Sensitizes Plasmodium falciparum to the Antimalarial Drug Piperaquine
Angana Mukherjee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017
Elizabeth Davlantes et al.
MALARIA JOURNAL (2018)
Efficacy and safety of artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Sudan: a systematic review and meta-analysis
Ishag Adam et al.
MALARIA JOURNAL (2018)
Drug resistance in Plasmodium
Kasturi Haldar et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda
Vito Baraka et al.
PLOS ONE (2018)
Evolutionary ARMS Race: Antimalarial Resistance Molecular Surveillance
Christiane Prosser et al.
TRENDS IN PARASITOLOGY (2018)
Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum
Selina Bopp et al.
NATURE COMMUNICATIONS (2018)
How to combat emerging artemisinin resistance: Lessons from The Three Little Pigs
Thanat Chookajorn
PLOS PATHOGENS (2018)
Plasmodium falciparum drug resistance gene status in the Horn of Africa: A systematic review
Abdullahi Jalei Abdifatah et al.
African Journal of Pharmacy and Pharmacology (2018)
Absence of a High Level of Duplication of the Plasmepsin Gene in Africa
Marie Gladys Robert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling
Saber Dini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
Leila S. Ross et al.
NATURE COMMUNICATIONS (2018)
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
Mwaka A. Kakolwa et al.
MALARIA JOURNAL (2018)
Evidence of Artemisinin-Resistant Plasmodium falciparum Malaria in Eastern India
Sabyasachi Das et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination
Manel Ouji et al.
PARASITE (2018)
Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014-2016
Mie Ikeda et al.
EMERGING INFECTIOUS DISEASES (2018)
Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
Juliana Inoue et al.
EMERGING INFECTIOUS DISEASES (2018)
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis
Li-Juan Zhou et al.
PARASITOLOGY RESEARCH (2017)
Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons
Reginald A. Kavishe et al.
FEBS JOURNAL (2017)
Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study
Roberto Amato et al.
LANCET INFECTIOUS DISEASES (2017)
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2017)
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015
Mateusz M. Plucinski et al.
MALARIA JOURNAL (2017)
What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism
Sarah Tougher et al.
MALARIA JOURNAL (2017)
Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination
Judith Recht et al.
MALARIA JOURNAL (2017)
Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea)
Pedro Berzosa et al.
MALARIA JOURNAL (2017)
Presence of quintuple dhfr N51, C59, S108-dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso
Esmee Ruizendaal et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2017)
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
Benjamin Blasco et al.
NATURE MEDICINE (2017)
Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa
Feng Lu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Efficacy of artesunate plus sulphadoxine/pyrimethamine and artemether plus lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy
Marian Warsame et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2017)
Antimalarial Drug Resistance: A Threat to Malaria Elimination
Didier Menard et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate plus sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014
Sweta Mishra et al.
PATHOGENS AND GLOBAL HEALTH (2017)
Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003-2015: a modelling study using data from national surveys
Adam Bennett et al.
LANCET GLOBAL HEALTH (2017)
Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa
Lucy C. Okell et al.
SCIENTIFIC REPORTS (2017)
Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: A malaria elimination point of view
Priyanka Patel et al.
SCIENTIFIC REPORTS (2017)
Distribution of Mutations Associated with Antifolate and Chloroquine Resistance among Imported Plasmodium vivax in the State of Qatar
Devendra Bansal et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial
Adoke Yeka et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Mutational prevalence of chloroquine resistance transporter gene among Plasmodium falciparum field isolates in Assam and Arunachal Pradesh, India
J. Sharma et al.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia
Sabina Dahlstrom Otienoburu et al.
MALARIA JOURNAL (2016)
Plasmodium falciparum: multifaceted resistance to artemisinins
Lucie Paloque et al.
MALARIA JOURNAL (2016)
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
D. Menard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
Paul Sondo et al.
PLOS ONE (2016)
Surveillance of Artemisinin Resistance in Plasmodium falciparum in India Using the kelch13 Molecular Marker
Neelima Mishra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Emergence of sulfadoxine-pyrimethamine resistance in Indian isolates of Plasmodium falciparum in the last two decades
Amit Kumar et al.
INFECTION GENETICS AND EVOLUTION (2015)
Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola
Kinanga Kiaco et al.
MALARIA JOURNAL (2015)
A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria
Alassane Mbengue et al.
NATURE (2015)
Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles
Marian Warsame et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2015)
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
Jigang Wang et al.
NATURE COMMUNICATIONS (2015)
The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs
Natalie Jane Spillman et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2015)
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Judith Straimer et al.
SCIENCE (2015)
Double Mutation in the pfmdr1 Gene Is Associated with Emergence of Chloroquine-Resistant Plasmodium falciparum Malaria in Eastern India
Sabyasachi Das et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Role of Pfmdr1 in In Vitro Plasmodium falciparum Susceptibility to Chloroquine, Quinine, Monodesethylamodiaquine, Mefloquine, Lumefantrine, and Dihydroartemisinin
Nathalie Wurtz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
Ric N. Price et al.
LANCET INFECTIOUS DISEASES (2014)
Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India
Neelima Mishra et al.
MALARIA JOURNAL (2014)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
Reduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia
Benoit Witkowski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
High Prevalence of Asymptomatic Malaria in a Tribal Population in Eastern India
Swagata Ganguly et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Plasmodium falciparum Drug Resistance Phenotype as Assessed by Patient Antimalarial Drug Levels and Its Association With pfmdr1 Polymorphisms
Maja Malmberg et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A clinical and molecular study of artesunate plus sulphadoxine-pyrimethamine in three districts of central and eastern India
Prakriti Srivastava et al.
MALARIA JOURNAL (2013)
Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan
Nahla B. Gadalla et al.
MALARIA JOURNAL (2013)
Altered temporal response of malaria parasites determines differential sensitivity to artemisinin
Nectarios Klonis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria
Inbarani Naidoo et al.
TRENDS IN PARASITOLOGY (2013)
Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy
Sanjeev Krishna et al.
TRENDS IN PARASITOLOGY (2013)
Comparative Efficacies of Artemisinin Combination Therapies in Plasmodium falciparum Malaria and Polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps Genes in Tea Gardens of Jalpaiguri District, India
Pabitra Saha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Lack of Association of the S769N Mutation in Plasmodium falciparum SERCA (PfATP6) with Resistance to Artemisinins
Long Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010
Neelima Mishra et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2012)
Endoplasmic Reticulum PI(3)P Lipid Binding Targets Malaria Proteins to the Host Cell
Souvik Bhattacharjee et al.
CELL (2012)
Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania
Erasmus Kamugisha et al.
MALARIA JOURNAL (2012)
A Major Genome Region Underlying Artemisinin Resistance in Malaria
Ian H. Cheeseman et al.
SCIENCE (2012)
Increased pfmdr1 Copy Number and Sequence Polymorphisms in Plasmodium falciparum Isolates from Sudanese Malaria Patients Treated with Artemether-Lumefantrine
Nahla B. Gadalla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Efficacy and Effectiveness of Artemether-Lumefantrine after Initial and Repeated Treatment in Children < 5 Years of Age with Acute Uncomplicated Plasmodium falciparum Malaria in Rural Tanzania: A Randomized Trial
Billy E. Ngasala et al.
CLINICAL INFECTIOUS DISEASES (2011)
Prolonged Selection of pfmdr1 Polymorphisms After Treatment of Falciparum Malaria With Artemether-Lumefantrine in Uganda
Frederick N. Baliraine et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study
Billy E. Ngasala et al.
MALARIA JOURNAL (2011)
High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children
Ghyslain Mombo-Ngoma et al.
MALARIA JOURNAL (2011)
Molecular Correlates of High-Level Antifolate Resistance in Rwandan Children with Plasmodium falciparum Malaria
Corine Karema et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Increased Tolerance to Artemisinin in Plasmodium falciparum Is Mediated by a Quiescence Mechanism
Benoit Witkowski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Selection of Known Plasmodium falciparum Resistance-Mediating Polymorphisms by Artemether-Lumefantrine and Amodiaquine Sulfadoxine-Pyrimethamine but Not Dihydroartemisinin-Piperaquine in Burkina Faso
Anyirekun Fabrice Some et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Phosphatidylinositol 3-Phosphate, an Essential Lipid in Plasmodium, Localizes to the Food Vacuole Membrane and the Apicoplast
Lina Tawk et al.
EUKARYOTIC CELL (2010)
Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations
Sankar Sridaran et al.
MALARIA JOURNAL (2010)
Selection of Plasmodium falciparum Multidrug Resistance Gene 1 Alleles in Asexual Stages and Gametocytes by Artemether-Lumefantrine in Nigerian Children with Uncomplicated Falciparum Malaria
C. T. Happi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Plasmodium falciparum Na+/H+ Exchanger 1 Transporter Is Involved in Reduced Susceptibility to Quinine
Maud Henry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Role of Plasmodium falciparum Digestive Vacuole Plasmepsins in the Specificity and Antimalarial Mode of Action of Cysteine and Aspartic Protease Inhibitors
Pedro A. Moura et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Discovery, mechanisms of action and combination therapy of artemisinin
Liwang Cui et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali
Abdoulaye A. Djimde et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2008)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Return of chloroquine antimalarial efficacy in Malawi
Miriam K. Laufer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6
R Jambou et al.
LANCET (2005)
Contribution of the pfmdr1 gene to antimalarial drug-resistance
MT Duraisingh et al.
ACTA TROPICA (2005)
Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance
PG Bray et al.
MOLECULAR MICROBIOLOGY (2005)
Mechanisms of resistance of malaria parasites to antifolates
A Gregson et al.
PHARMACOLOGICAL REVIEWS (2005)
Resistance to antimalarials in southeast Asia and genetic polymorphisms in pfmdr1
AL Pickard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations
ABS Sidhu et al.
SCIENCE (2002)
Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site
M Korsinczky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
